Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving Tolerability of Statins With Ubiquinone (Co-enzyme Q10)
2006-001198-18Phase 2Completed
- Sponsor
- Sligo University Hospital
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of coenzyme q10 in type 2 diabetes mellitus (T2DM), dyslipidemia, coronary arteriosclerosis and 1 more, sponsored by Sligo University Hospital. Primary endpoint: Resolution of fatigue and myopathy. Started Mar 2006; status: completed.
02
Drugs
coenzyme q10
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemiacoronary arteriosclerosisstatin-associated myopathy (SAMS)
Beyond the preview
Go deeper on 2006-001198-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001198-18.